Molecular Templates (MTEM) Short Interest Ratio & Short Volume → How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad) Free MTEM Stock Alerts $1.64 +0.09 (+5.81%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Molecular Templates Short Interest DataCurrent Short Volume33,800 sharesPrevious Short Volume27,300 sharesChange Vs. Previous Month+23.81%Dollar Volume Sold Short$75,712.00Short Interest Ratio / Days to Cover0.6Last Record DateMarch 31, 2024Outstanding Shares5,370,000 sharesFloat Size2,950,000 sharesShort Percent of Float1.15%Today's Trading Volume14,777 sharesAverage Trading Volume52,380 sharesToday's Volume Vs. Average28% Short Selling Molecular Templates ? Sign up to receive the latest short interest report for Molecular Templates and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMTEM Short Interest Over TimeMTEM Days to Cover Over TimeMTEM Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Molecular Templates Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202433,800 shares $75,712.00 +23.8%1.2%0.6 $2.24 3/15/202427,300 shares $75,075.00 -29.8%0.6%1.8 $2.75 2/29/202438,900 shares $149,765.00 -31.4%0.9%3.6 $3.85 2/15/202456,700 shares $205,254.00 -9.6%1.3%6.3 $3.62 1/31/202462,700 shares $220,077.00 +6.3%1.4%6.7 $3.51 1/15/202459,000 shares $212,400.00 -9.0%1.4%6.2 $3.60 Get the Latest News and Ratings for MTEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Templates and its competitors with MarketBeat's FREE daily newsletter. 12/31/202364,800 shares $241,704.00 +76.1%1.5%6.8 $3.73 12/15/202336,800 shares $134,688.00 -45.1%0.8%4.2 $3.66 11/30/202367,000 shares $326,960.00 -0.5%1.5%8 $4.88 11/15/202367,300 shares $351,306.00 +2.0%1.5%8.4 $5.22 10/31/202366,000 shares $363,000.00 +11.5%1.5%7.3 $5.50 10/15/202359,200 shares $377,790.72 +1.7%1.4%6.1 $6.38 9/30/202358,200 shares $367,824.00 -6.9%1.3%3.8 $6.32 9/15/202362,500 shares $428,750.00 +9.3%1.4%4.2 $6.86 8/31/202357,200 shares $486,772.00 -39.9%1.3%4 $8.51 8/15/202395,100 shares $789,330.00 -88.3%2.2%6.3 $8.30 7/31/2023809,600 shares $486,569.60 -17.5%N/A3.9 $0.60 7/15/2023981,100 shares $483,682.30 +3.8%N/A5.3 $0.49 6/30/2023945,100 shares $453,648.00 -12.5%2.1%8.3 $0.48 6/15/20231,080,000 shares $539,892.00 +1.9%2.4%7 $0.50 5/31/20231,060,000 shares $498,200.00 +1.9%2.3%1.4 $0.47 5/15/20231,040,000 shares $436,800.00 -14.8%2.3%1.4 $0.42 4/30/20231,220,000 shares $479,338.00 -12.9%2.7%1.6 $0.39 4/15/20231,400,000 shares $658,000.00 +40.0%3.1%1.8 $0.47 3/31/20231,000,000 shares $379,900.00 -5.7%2.3%1.3 $0.38 3/15/20231,060,000 shares $349,906.00 +187.2%2.5%1.4 $0.33 2/28/2023369,100 shares $173,477.00 +27.2%0.9%2.7 $0.47 2/15/2023290,200 shares $139,644.24 -15.9%0.7%1.8 $0.48 1/31/2023345,100 shares $186,008.90 +5.5%0.8%2.1 $0.54 1/15/2023327,200 shares $150,577.44 -6.3%0.7%2.1 $0.46 12/30/2022349,000 shares $114,472.00 -17.7%0.8%2.3 $0.33 12/15/2022423,900 shares $190,755.00 -4.4%1.0%3.2 $0.45 11/30/2022443,500 shares $235,010.65 +3.4%1.0%3.6 $0.53 11/15/2022429,100 shares $272,735.96 -19.6%1.0%4.1 $0.64 10/31/2022533,500 shares $316,952.35 +1.0%1.2%5.4 $0.59 10/15/2022528,100 shares $343,159.38 +7.4%1.3%4.8 $0.65 9/30/2022491,800 shares $368,702.46 -6.9%1.2%4.2 $0.75 9/15/2022528,100 shares $417,938.34 +40.1%1.3%2.5 $0.79 8/31/2022376,900 shares $276,531.53 +18.0%0.9%1.6 $0.73 8/15/2022319,300 shares $309,273.98 +1.5%0.8%1.2 $0.97Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. MTEM Short Interest - Frequently Asked Questions What is Molecular Templates' current short interest? Short interest is the volume of Molecular Templates shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 33,800 shares of MTEM short. 1.15% of Molecular Templates' shares are currently sold short. Learn More on Molecular Templates' current short interest. What is a good short interest ratio for Molecular Templates? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MTEM shares currently have a short interest ratio of 1.0. Learn More on Molecular Templates's short interest ratio. What is a good short interest percentage for Molecular Templates? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.15% of Molecular Templates' floating shares are currently sold short. Is Molecular Templates' short interest increasing or decreasing? Molecular Templates saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 33,800 shares, an increase of 23.8% from the previous total of 27,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Molecular Templates' float size? Molecular Templates currently has issued a total of 5,370,000 shares. Some of Molecular Templates' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Molecular Templates currently has a public float of 2,950,000 shares. How does Molecular Templates' short interest compare to its competitors? 1.15% of Molecular Templates' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Molecular Templates: Virios Therapeutics, Inc. (1.13%), NuCana plc (0.35%), Cyclerion Therapeutics, Inc. (1.18%), Hepion Pharmaceuticals, Inc. (1.47%), Lixte Biotechnology Holdings, Inc. (0.97%), ASLAN Pharmaceuticals Limited (0.73%), Biofrontera Inc. (0.95%), TFF Pharmaceuticals, Inc. (3.44%), Bionomics Limited (3.17%), Chemomab Therapeutics Ltd. (1.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Templates stock? Short selling MTEM is an investing strategy that aims to generate trading profit from Molecular Templates as its price is falling. MTEM shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Templates? A short squeeze for Molecular Templates occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MTEM, which in turn drives the price of the stock up even further. How often is Molecular Templates' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTEM, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Virios Therapeutics Short Squeeze NuCana Short Squeeze Cyclerion Therapeutics Short Squeeze Hepion Pharmaceuticals Short Squeeze Lixte Biotechnology Short Squeeze ASLAN Pharmaceuticals Short Squeeze Biofrontera Short Squeeze TFF Pharmaceuticals Short Squeeze Bionomics Short Squeeze Chemomab Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MTEM) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing